(Q42666741)

4 November 2017

title

Efficacy and safety of voriconazole in the treatment of chronic pulmonary aspergillosis: experience in Japan (English)

1 reference

chronic pulmonary aspergillosis

4 November 2017

0 references

1 reference

1 reference

T Saito

1

1 reference

4 November 2017

S Fujiuchi

2

1 reference

4 November 2017

Y Tao

3

1 reference

4 November 2017

Y Sasaki

4

1 reference

4 November 2017

K Ogawa

5

1 reference

4 November 2017

K Suzuki

6

1 reference

4 November 2017

A Tada

7

1 reference

4 November 2017

M Kuba

8

1 reference

4 November 2017

T Kato

9

1 reference

4 November 2017

M Kawabata

10

1 reference

4 November 2017

A Kurashima

11

1 reference

4 November 2017

M Sakatani

12

1 reference

4 November 2017

NHO Pulmonary Fungosis Research Group

13

1 reference

4 November 2017

publication date

7 September 2012

1 reference

4 November 2017

1 reference

4 November 2017

volume

40

1 reference

4 November 2017

issue

6

1 reference

4 November 2017

page(s)

661-667

1 reference

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0322-X

Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0322-X

Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0322-X

Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0322-X

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0322-X

Voriconazole, a novel wide‐spectrum triazole: oral pharmacokinetics and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0322-X

Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: a dose escalation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0322-X

Intravenous micafungin versus voriconazole for chronic pulmonary aspergillosis: a multicenter trial in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0322-X

In Vitro Activities of Three Licensed Antifungal Agents against Spanish Clinical Isolates of Aspergillus spp

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0322-X

The efficacy and tolerability of voriconazole in the treatment of chronic cavitary pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0322-X

Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0322-X

Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients

21 January 2018

1 reference

12 December 2020

Galactomannan detection for invasive aspergillosis in immunocompromized patients

1 reference

12 December 2020

Itraconazole therapy in aspergillosis: study in 49 patients

1 reference

12 December 2020

"Semi-invasive" pulmonary aspergillosis: a new look at the spectrum of aspergillus infections of the lung

1 reference

12 December 2020

Clinical efficacy and safety of micafungin in Japanese patients with chronic pulmonary aspergillosis: a prospective observational study

1 reference

12 December 2020

Chronic necrotizing pulmonary aspergillosis: a discrete clinical entity.

1 reference

12 December 2020

Comparison of Aspergillus galactomannan antigen testing with a new cut-off index and Aspergillus precipitating antibody testing for the diagnosis of chronic pulmonary aspergillosis

1 reference

12 December 2020

10.1007/S15010-012-0322-X

Identifiers

DOI

1 reference

4 November 2017

1 reference